Becton, Dickinson and Co.
As on 16 Oct, 2025 | 01:29 IST
| Open | 187.59 |
| Previous Close | 188.36 |
| Beta | 0.38 |
| High | 189.57 |
| Low | 185.97 |
| TTM EPS See historical trend | 14.27(+11.75% YoY) |
| 52 Week High | 251.38 |
| 52 Week Low | 163.46 |
| TTM PE See historical trend | 13.09(Low PE) |
| Mkt. Cap ($ Billion) | 54.18 |
| Dividend Yield | 2.36 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 187.7 |
| 10 | 190.18 |
| 20 | 188.2 |
| 50 | 190.36 |
| 100 | 182.76 |
| 200 | 199.87 |
Returns
| 1 Week | -3.58% | |
| 1 Month | 0.47% | |
| 3 Months | 4.83% | |
| YTD | -17.57% | |
| 1 Year | -22.71% | |
| 3 Years | -16.90% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 191.20 | 0.18 | 460.75 | 19.12 | 10.00 | 3.29 | 194.24/141.30 | 7.75 | Very Bullish |
| Abbott | 129.46 | -2.86 | 224.61 | 26.43 | 4.90 | 1.71 | 141.07/110.89 | -1.39 | Very Bearish |
| Thermo Fisher Scientific | 527.31 | 0.28 | 201.26 | 24.11 | 21.89 | 0.41 | 610.77/385.72 | 11.16 | Very Bullish |
| Intuitive Surgical | 435.61 | -0.18 | 154.42 | 54.12 | 8.05 | -- | 614.58/427.84 | 0.41 | Very Bearish |
| Danaher | 206.30 | 0.07 | 148.88 | 27.37 | 7.53 | 0.59 | 278.31/171.26 | 9.49 | Very Bullish |
Market news
- Dow, S&P 500 manage record closing highs; Nasdaq falls in volatile sessionOctober 4, 2025 9:34 AM
- Wall Street closes higher, boosted by healthcare as investors shrug off jobs data, US shutdownOctober 2, 2025 8:05 AM
- Wall Street ends streak of weekly gains, yields rise as investors digest dataSeptember 27, 2025 8:50 AM
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
About the company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.